Chia-Hao Liu
Overview
Explore the profile of Chia-Hao Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen K, Chang J, Sularz A, Lo Russo G, Saleh G, Chang S, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e037545.
PMID: 40008509
No abstract available.
2.
Wang P, Liu C, Yang S
Taiwan J Obstet Gynecol
. 2024 Oct;
63(6):817-819.
PMID: 39481985
No abstract available.
3.
Saleh G, Sularz A, Liu C, Lo Russo G, Adi M, Attia Z, et al.
JACC Adv
. 2024 Oct;
3(9):101171.
PMID: 39372454
No abstract available.
4.
Wang P, Yang S, Liu C
Taiwan J Obstet Gynecol
. 2024 Sep;
63(5):597-598.
PMID: 39266135
No abstract available.
5.
The Complexities of Multivalvular Disease Management: Navigating Known Unknowns and Unknown Unknowns
Al-Abcha A, Liu C, Alkhouli M
JACC Cardiovasc Interv
. 2024 Aug;
17(16):1932-1935.
PMID: 39197991
No abstract available.
6.
Lo Russo G, Balla A, Alarouri H, Liu C, Adi M, Killu A, et al.
Heart Rhythm
. 2024 Jul;
22(2):495-502.
PMID: 39032523
Background: Short-term antithrombotic therapy is recommended after left atrial appendage occlusion (LAAO) to reduce the risk of device-related thrombosis. However, patients referred for LAAO have excess bleeding risk. Yet, short-term...
7.
Wang P, Yang S, Liu C
Taiwan J Obstet Gynecol
. 2024 Jul;
63(4):448-450.
PMID: 39004469
No abstract available.
8.
Liu C, Yang S, Wang P
Taiwan J Obstet Gynecol
. 2024 Jul;
63(4):446-447.
PMID: 39004468
No abstract available.
9.
Wang P, Liu C, Yang S
Taiwan J Obstet Gynecol
. 2024 Jul;
63(4):443-445.
PMID: 39004467
No abstract available.
10.
Liu C, Lee H, Liou J, Hua H, Cheng W, Yuliani F, et al.
Eur J Pharmacol
. 2024 Jun;
977:176711.
PMID: 38839029
Histone deacetylase (HDAC) inhibitors are potential candidates for treating pulmonary fibrosis. MPT0E028, a novel pan-HDAC inhibitor, has been reported to exhibit antitumor activity in several cancer cell lines. In this...